1. CMU Intellectual Repository
  2. Academic Support Units
  3. Chiang Mai University Library
  4. CMUL: Journal Articles
Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/65731
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNicolas Salvadorien_US
dc.contributor.authorBo Fanen_US
dc.contributor.authorWaralee Teeyasoontranonen_US
dc.contributor.authorNicole Ngo-Giang-Huongen_US
dc.contributor.authorSiriluk Phanomcheongen_US
dc.contributor.authorAnita Luviraen_US
dc.contributor.authorAchara Puangsombaten_US
dc.contributor.authorArunrat Suwannaraten_US
dc.contributor.authorUssanee Srirompotongen_US
dc.contributor.authorChaiwat Putiyanunen_US
dc.contributor.authorTim R. Cresseyen_US
dc.contributor.authorLuc Deckeren_US
dc.contributor.authorWoottichai Khamduangen_US
dc.contributor.authorLinda Harrisonen_US
dc.contributor.authorCamlin Tierneyen_US
dc.contributor.authorJohn A. Shepherden_US
dc.contributor.authorAthena P. Kourtisen_US
dc.contributor.authorMarc Bulterysen_US
dc.contributor.authorGeorge K. Siberryen_US
dc.contributor.authorGonzague Jourdainen_US
dc.date.accessioned2019-08-05T04:40:10Z-
dc.date.available2019-08-05T04:40:10Z-
dc.date.issued2019-06-18en_US
dc.identifier.issn15376591en_US
dc.identifier.other2-s2.0-85068428450en_US
dc.identifier.other10.1093/cid/ciy982en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068428450&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/65731-
dc.description.abstract© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. In a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of hepatitis B virus, there was no significant effect of maternal TDF use on maternal or infant bone mineral density 1 year after delivery/birth. Clinical Trials Registration. NCT01745822.en_US
dc.subjectMedicineen_US
dc.titleMaternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virusen_US
dc.typeJournalen_US
article.title.sourcetitleClinical infectious diseases : an official publication of the Infectious Diseases Society of Americaen_US
article.volume69en_US
article.stream.affiliationsHarvard School of Public Healthen_US
article.stream.affiliationsNakornping Hospitalen_US
article.stream.affiliationsOrganisation Mondiale de la Santéen_US
article.stream.affiliationsBanglamung Hospitalen_US
article.stream.affiliationsUniversity of California, San Franciscoen_US
article.stream.affiliationsCenters for Disease Control and Preventionen_US
article.stream.affiliationsUniversity of Liverpoolen_US
article.stream.affiliationsNational Institute of Child Health and Human Developmenten_US
article.stream.affiliationsUniversity of Hawaii at Manoaen_US
article.stream.affiliationsKhon Kaen Regional Hospitalen_US
article.stream.affiliationsCenter for Biostatistics in AIDS Researchen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsNopparat Rajathanee Hospitalen_US
article.stream.affiliationsSamutprakarn Hospitalen_US
article.stream.affiliationsChiang Kham Hospitalen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.